primary and secondary
Showing 1 - 25 of >10,000
Response To Dengue Exposure Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (rDENdelta30/31-7164)
Not yet recruiting
- Response To Dengue Exposure
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Lymphedema Trial (Micro-biopsies)
Not yet recruiting
- Lymphedema
- Micro-biopsies
- (no location specified)
Jan 2, 2023
Rheumatic Heart Disease Trial in Kampala (Primary Training Phase, Primary Assessment Phase, Primary Screening Phase)
Active, not recruiting
- Rheumatic Heart Disease
- Primary Training Phase
- +5 more
-
Kampala, UgandaUganda Heart Institute
Jan 27, 2023
Tooth Loss Trial (Transalveolar crest maxillary sinus floor lift, transalveolar crest parietal maxillary sinus floor secondary
Not yet recruiting
- Tooth Loss
- Transalveolar crest maxillary sinus floor lift
- transalveolar crest parietal maxillary sinus floor secondary lift
- (no location specified)
Oct 24, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)
Not yet recruiting
- Primary Central Nervous System Lymphoma
- +3 more
- Pemetrexed
- +3 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 23, 2022
The Initiating Factors of Myopia Among Primary and Secondary
Recruiting
- Myopia; Refractive Error
- No intervention
-
Tianjin, Tianjin, ChinaTianjin Eye Hospital
Nov 26, 2022
Takotsubo Cardiomyopathy, Sepsis-induced Cardiomyopathy Trial in Rome (Positron Emission Tomography (PET) analysis, Blood
Not yet recruiting
- Takotsubo Cardiomyopathy
- Sepsis-induced Cardiomyopathy
- Positron Emission Tomography (PET) analysis
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 29, 2023
CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic
Not yet recruiting
- Chronic Kidney Diseases
- (no location specified)
Jul 18, 2023
Overdose Trial in Baltimore (Peer Education, Narcan Nasal Product)
Recruiting
- Overdose
- Peer Education
- Narcan Nasal Product
-
Baltimore, MarylandLighthouse Studies at Peer Point
Jan 9, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Subcutaneous Immunoglobulin in Primary and Secondary
Not yet recruiting
- Primary Immune Deficiency Disorder
- Secondary Immune Deficiency
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jun 14, 2022
Fycompa Tablets in Adolescence Epilepsy Partial-onset Seizures
Completed
- Partial Seizures (With or Without Secondary Generalized Seizures)
- Primary Generalized Tonic-clonic Seizures
-
Osaka, Japan
- +1 more
Aug 3, 2022
Diabetes, Health Behaviors Trial in Jerusalem (Attention-control, Community based intervention with resilience training,
Recruiting
- Diabetes
- Health Behaviors
- Attention-control
- +3 more
-
Jerusalem, IsraelBeit-Safafa community center
Jun 16, 2022
Primary Aldosteronism, Resistant Hypertension, Secondary Hypertension Trial in Boston (Best Practice Advisory Computerized
Not yet recruiting
- Primary Aldosteronism
- +5 more
- Best Practice Advisory Computerized Alert
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 22, 2023
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Saint Louis (Durvalumab, Acalabrutinib)
Recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
-
Saint Louis, MissouriWashington University School of Medicine
Mar 14, 2022
Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Primary Central Nervous System Lymphoma
- Secondary Central Nervous System Lymphoma
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jul 31, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Multiple Sclerosis Trial (Intranasal Foralumab
Withdrawn
- Primary Progressive Multiple Sclerosis
- +2 more
- Intranasal Foralumab Solution
- Placebo
- (no location specified)
Feb 14, 2022
Endodontically Treated Teeth, Post Operative Pain Trial in Ajman (cryotherapy with sterile saline at 2.5ºC, control with sterile
Active, not recruiting
- Endodontically Treated Teeth
- Post Operative Pain
- cryotherapy with sterile saline at 2.5ºC
- control with sterile saline at room temperature
-
Ajman, United Arab EmiratesAjman University
Nov 11, 2023
Primary and Secondary Lymphatic Disorders
Recruiting
- Lymphangiomatosis
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)
Active, not recruiting
- Influenza
- +3 more
- Fluzone® quadrivalent
- +5 more
-
Stanford, CaliforniaStanford LPCH Vaccine Program
Dec 12, 2022
Secondary Malignant Tumor of Retroperitoneum, Secondary Malignant Tumor of Peritoneum, Pseudomyxoma Peritonei Trial in Cleveland
Not yet recruiting
- Secondary Malignant Neoplasm of Retroperitoneum
- +2 more
- Intestinal, Multivisceral or Modified Multivisceral Transplantation
- +3 more
-
Cleveland, OhioCleveland Clinic Digestive Disease & Surgery Institute (DDSI), C
Oct 10, 2023
